CGCCanopy Growth Corporation
$0.67-49% 1Y
$0.67
$0.6652 weeks$1.92
New on file: delisting notice / listing-rule failureOct 16, 2026what changed →
Is the price fair?
What CGC's price assumes
Canopy Growth Corporation did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 1.41× revenue.
1.41
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 0.57
Price / book · as of 2026-Q1
- EV / sales
- 1.11
EV / sales
Details›
- Price / bookas of 2026-Q1
- 0.57
- EV / EBIToperating margin −55%: the multiple describes the denominator
- not meaningful
- EV / salesas of 2026-Q1
- 1.11
- Market capitalisation423.0 million shares, counted Aug 5, 2026
- $285M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Drug Manufacturers, Specialty & Generic
Ranks #26 of 39 by RyuScore